HIND vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

HIND

64.3
AI Score
VS
HIND Wins

CLYM

53.3
AI Score

Investment Advisor Scores

HIND

64score
Recommendation
BUY

CLYM

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HIND CLYM Winner
Net Income -1.45M -27.22M HIND
Operating Income -1.01M -30.57M HIND
ROE 33.0% -11.4% HIND
ROA -104.8% -11.1% CLYM
Total Assets 1.38M 246.29M CLYM
Cash 101,904 44.11M CLYM
Current Ratio 0.05 31.45 CLYM

Relative Price Performance (Last 90 Days)

HIND 1M: -8.1% · 3M: -4.7% CLYM 1M: -21.4% · 3M: -12.2%

Current Technical Phase

HIND

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.9 · Price: $2.03

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 32.9 · Price: $11.45

Fundamentals Snapshot

Metric HIND CLYM
Market Cap — —
Forward P/E -2.5 -11.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.5% 0.0%
Gross Margin 0.5% —
Operating Margin -32.0% 0.0%
EPS -1.61 -0.82
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HIND is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.